Search Results - "Gonzalez, Nilda M."

Risperidone for the Core Symptom Domains of Autism: Results From the Study by the Autism Network of the Research Units on Pediatric Psychopharmacology by McDougle, Christopher J., Scahill, Lawrence, Aman, Michael G., McCracken, James T., Tierney, Elaine, Davies, Mark, Arnold, L. Eugene, Posey, David J., Martin, Andrès, Ghuman, Jaswinder K., Shah, Bhavik, Chuang, Shirley Z., Swiezy, Naomi B., Gonzalez, Nilda M., Hollway, Jill, Koenig, Kathleen, McGough, James J., Ritz, Louise, Vitiello, Benedetto

“…OBJECTIVE: Risperidone has been found efficacious for decreasing severe tantrums, aggression, and self-injurious behavior in children and adolescents with…”
Get full text

Risperidone in Children with Autism and Serious Behavioral Problems by McCracken, James T, McGough, James, Shah, Bhavik, Cronin, Pegeen, Hong, Daniel, Aman, Michael G, Arnold, L. Eugene, Lindsay, Ronald, Nash, Patricia, Hollway, Jill, McDougle, Christopher J, Posey, David, Swiezy, Naomi, Kohn, Arlene, Scahill, Lawrence, Martin, Andres, Koenig, Kathleen, Volkmar, Fred, Carroll, Deirdre, Lancor, Allison, Tierney, Elaine, Ghuman, Jaswinder, Gonzalez, Nilda M, Grados, Marco, Vitiello, Benedetto, Ritz, Louise, Davies, Mark, Robinson, James, McMahon, Don

“…Serious behavioral problems in children with autism are common and difficult to manage. Atypical antipsychotic medications are effective in treating adults…”
Get full text

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials by Arnold, L Eugene, Vitiello, Benedetto, McDougle, Christopher, Scahill, Larry, Shah, Bhavik, Gonzalez, Nilda M, Chuang, Shirley, Davies, Mark, Hollway, Jill, Aman, Michael G, Cronin, Pegeen, Koenig, Kathleen, Kohn, Arlene E, McMahon, Donald J, Tierney, Elaine

“…A consumer-oriented efficacy assessment in clinical trials should measure changes in chief complaint and consumer request (symptoms of most concern to…”
Get more information

Acute and long-term safety and tolerability of risperidone in children with autism by Aman, Michael G, Arnold, L Eugene, McDougle, Christopher J, Vitiello, Benedetto, Scahill, Lawrence, Davies, Mark, McCracken, James T, Tierney, Elaine, Nash, Patricia L, Posey, David J, Chuang, Shirley, Martin, Andres, Shah, Bhavik, Gonzalez, Nilda M, Swiezy, Naomi B, Ritz, Louise, Koenig, Kathleen, McGough, James, Ghuman, Jaswinder K, Lindsay, Ronald L

“…Treatment-emergent adverse events (AEs) were monitored during an 8-week, double-blind, placebo-controlled trial of risperidone (0.5-3.5 mg/day) in 101 children…”
Get more information

Children's Yale-Brown Obsessive Compulsive Scale Modified for Pervasive Developmental Disorders by Scahill, Lawrence, McDougle, Christopher J, Williams, Susan K, Dimitropoulos, Anastasia, Aman, Michael G, McCracken, James T, Tierney, Elaine, Arnold, L. Eugene, Cronin, Pegeen, Grados, Marco, Ghuman, Jaswinder, Koenig, Kathleen, Lam, Kristen S. L, McGough, James, Posey, David J, Ritz, Louise, Swiezy, Naomi B, Vitiello, Benedetto

“…Objective: To examine the psychometric properties of the Children's Yale-Brown Obsessive Compulsive Scales (CYBOCS) modified for pervasive developmental…”
Get more information

A prospective open trial of guanfacine in children with pervasive developmental disorders by Scahill, Lawrence, Aman, Michael G, McDougle, Christopher J, McCracken, James T, Tierney, Elaine, Dziura, James, Arnold, L Eugene, Posey, David, Young, Christopher, Shah, Bhavik, Ghuman, Jaswinder, Ritz, Louise, Vitiello, Benedetto

“…A common complaint for children with pervasive developmental disorder (PDD) is hyperactivity. The purpose of this pilot study was to gather preliminary…”
Get more information

Naltrexone in autistic children: behavioral symptoms and attentional learning by Campbell, M, Anderson, L T, Small, A M, Adams, P, Gonzalez, N M, Ernst, M

“…To assess critically the short-term efficacy and safety of naltrexone in autistic children and its effects on discrimination learning in the laboratory. A…”
Get more information

Last Chance High: How Girls and Boys Drop In and Out of Alternative Schools. Deirdre M. Kelly by Flores-Gonzalez, Nilda M.

Get full text

Child and adolescent psychiatry for the specialty board review by Gonzalez, Nilda M.

Get full text

Last Chance High: How Girls and Boys Drop In and Out of Alternative Schools by Kelly, Deirdre M, Flores-Gonzalez, Nilda M

Get full text

Randomized, Controlled, Crossover Trial of Methylphenidate in Pervasive Developmental Disorders With Hyperactivity

“…CONTEXT Hyperactivity and inattention are common symptoms in children with autistic disorder and related pervasive developmental disorders, but studies of…”
Get full text

Utility of uroplakin II expression as a marker of urothelial carcinoma by Tian, Wei, MD, Guner, Gunes, MD, Miyamoto, Hiroshi, MD, PhD, Cimino-Mathews, Ashley, MD, Gonzalez-Roibon, Nilda, MD, Argani, Pedram, MD, Li, Xuan, MPH, MS, Sharma, Rajni, PhD, Subhawong, Andrea P., MD, Rezaei, Katayoon, MD, Bivalacqua, Trinity J., MD, PhD, Epstein, Jonathan I., MD, Bishop, Justin A., MD, Netto, George J., MD

“…Summary Uroplakins are markers of terminally differentiated urothelium. Uroplakin II (UPII) is a newly described sensitive marker for urothelial carcinoma…”
Get full text

GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor by Miyamoto, Hiroshi, MD, PhD, Izumi, Koji, MD, Yao, Jorge L., MD, Li, Yi, MD, Yang, Qi, AAS, McMahon, Loralee A., MS, Gonzalez-Roibon, Nilda, MD, Hicks, David G., MD, Tacha, David, PhD, Netto, George J., MD

“…Summary Although GATA binding protein 3 , a zinc finger transcription factor and an estrogen receptor–regulated gene, has recently been suggested as a marker…”
Get full text

The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas by Gonzalez-Roibon, Nilda, MD, Albadine, Roula, MD, Sharma, Rajni, PhD, Faraj, Sheila F., MD, Illei, Peter B., MD, Argani, Pedram, MD, Ertoy, Dilek, MD, Allaf, Mohamad E., MD, Netto, George J., MD

“…Summary Differential diagnosis of collecting duct carcinoma (CDC) from invasive upper tract urothelial carcinoma (UTUC) can be challenging. PAX8 and p63 are 2…”
Get full text

ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder by Faraj, Sheila F., MD, Chaux, Alcides, MD, Gonzalez-Roibon, Nilda, MD, Munari, Enrico, MD, Ellis, Carla, MD, MS, Driscoll, Tina, BS, Schoenberg, Mark P., MD, Bivalacqua, Trinity J., MD, Shih, Ie-Ming, MD, PhD, Netto, George J., MD

“…Summary AT - rich interactive domain 1A ( ARID1A ) is tumor suppressor gene that interacts with BRG1 adenosine triphosphatase to form a SWI/SNF chromatin…”
Get full text

Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors by Gonzalez-Roibon, Nilda, MD, Katz, Betina, MD, Chaux, Alcides, MD, Sharma, Rajni, PhD, Munari, Enrico, MD, Faraj, Sheila F., MD, Illei, Peter B., MD, Torbenson, Michael, MD, Netto, George J., MD

“…Summary SALL4 is a transcription factor that serves as a marker of yolk sac tumor. Yolk sac tumor and hepatocellular carcinoma share histologic, serologic, and…”
Get full text

Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms by Gonzalez-Roibon, Nilda, MD, Faraj, Sheila F., MD, Munari, Enrico, MD, Bezerra, Stephania M., MD, Albadine, Roula, MD, Sharma, Rajni, PhD, Argani, Pedram, MD, Allaf, Mohamad E., MD, Netto, George J., MD

“…Summary Transcription factor GATA binding protein 3 (GATA3) has been suggested as a marker of urothelial carcinoma of the bladder and upper urinary tract. Its…”
Get full text

Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma by Munari, Enrico, MD, Fujita, Kazutoshi, MD, Faraj, Sheila, MD, Chaux, Alcides, MD, Gonzalez-Roibon, Nilda, MD, Hicks, Jessica, MS, Meeker, Alan, PhD, Nonomura, Norio, MD, Netto, George J., MD

“…Summary Upper tract urothelial carcinoma (UTUC) accounts for 5% to 10% of all urothelial carcinomas. Despite many shared features, key clinical and molecular…”
Get full text

Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases by Faraj, Sheila F., MD, Chaux, Alcides, MD, Gonzalez-Roibon, Nilda, MD, Munari, Enrico, MD, Cubilla, Antonio L., MD, Shih, Ie-Ming, MD, Netto, George J., MD

“…Summary ARID1A , a member of the chromatin remodeling genes family, has been suggested as a novel tumor suppressor gene in gynecologic malignancies. However,…”
Get full text

The pharmacologic treatment of conduct disorders and rage outbursts by Campbell, M, Gonzalez, N M, Silva, R R

“…Although this article focuses on psychopharmacology, pharmacotherapy is only part of a comprehensive treatment program. Treatment should be individualized to…”
Get more information